ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Name: Work Video:
Duration: 3 min 30 s
Nicola J. Clegg; John Wongvipat; James D. Joseph; Chris Tran; Samedy Ouk; Anna Dilhas; Yu Chen; Kate Grillot; Eric D. Bischoff; Ling Cai; Anna Aparicio; Steven Dorow; Vivek Arora; Gang Shao; Jing Qian; Hong Zhao; Guangbin Yang; Chunyan Cao; John Sensintaffar; Teresa Wasielewska; Mark R. Herbert; Céline Bonnefous; Beatrice Darimont; Howard I. Scher; Peter Smith‐Jones; Mark Klang; Nicholas D. Smith; Elisa de Stanchina; Nian Wu; Ouathek Ouerfelli; Peter J. Rix; Richard A. Heyman; Michael E. Jung; Charles L. Sawyers; Jeffrey H. Hager
{'id': 'https://openalex.org/W2084637523', 'doi': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'title': 'ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment', 'display_name': 'ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment', 'publication_year': 2012, 'publication_date': '2012-01-21', 'ids': {'openalex': 'https://openalex.org/W2084637523', 'doi': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'mag': '2084637523', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22266222', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3306502'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052812092', 'display_name': 'Nicola J. Clegg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nicola J. Clegg', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050228096', 'display_name': 'John Wongvipat', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Wongvipat', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037379407', 'display_name': 'James D. Joseph', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James D. Joseph', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108500086', 'display_name': 'Chris Tran', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chris Tran', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}, {'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004230969', 'display_name': 'Samedy Ouk', 'orcid': 'https://orcid.org/0000-0001-9866-3264'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Samedy Ouk', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040291560', 'display_name': 'Anna Dilhas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anna Dilhas', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100401992', 'display_name': 'Yu Chen', 'orcid': 'https://orcid.org/0000-0002-0171-3884'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yu Chen', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024913625', 'display_name': 'Kate Grillot', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kate Grillot', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050507826', 'display_name': 'Eric D. Bischoff', 'orcid': 'https://orcid.org/0009-0007-5868-9196'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Eric D. Bischoff', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027842285', 'display_name': 'Ling Cai', 'orcid': 'https://orcid.org/0000-0002-8592-5269'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ling Cai', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050565684', 'display_name': 'Anna Aparicio', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anna Aparicio', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109602150', 'display_name': 'Steven Dorow', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steven Dorow', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071620573', 'display_name': 'Vivek Arora', 'orcid': 'https://orcid.org/0000-0003-1694-9109'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vivek Arora', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100518237', 'display_name': 'Gang Shao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gang Shao', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001637232', 'display_name': 'Jing Qian', 'orcid': 'https://orcid.org/0000-0001-6120-5147'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jing Qian', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030949210', 'display_name': 'Hong Zhao', 'orcid': 'https://orcid.org/0000-0002-8069-9901'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hong Zhao', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104534376', 'display_name': 'Guangbin Yang', 'orcid': 'https://orcid.org/0000-0003-3797-0054'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Guangbin Yang', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}, {'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101564600', 'display_name': 'Chunyan Cao', 'orcid': 'https://orcid.org/0000-0002-7698-1381'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chunyan Cao', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006915014', 'display_name': 'John Sensintaffar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Sensintaffar', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038000748', 'display_name': 'Teresa Wasielewska', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Teresa Wasielewska', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023190441', 'display_name': 'Mark R. Herbert', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark R. Herbert', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072118690', 'display_name': 'Céline Bonnefous', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Celine Bonnefous', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012291117', 'display_name': 'Beatrice Darimont', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Beatrice Darimont', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072850546', 'display_name': 'Howard I. Scher', 'orcid': 'https://orcid.org/0000-0002-6791-9324'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Howard I. Scher', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013739700', 'display_name': 'Peter Smith‐Jones', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peter Smith-Jones', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053893955', 'display_name': 'Mark Klang', 'orcid': 'https://orcid.org/0000-0002-8753-9783'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Klang', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102820332', 'display_name': 'Nicholas D. Smith', 'orcid': 'https://orcid.org/0000-0001-5791-8849'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nicholas D. Smith', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}, {'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004111432', 'display_name': 'Elisa de Stanchina', 'orcid': 'https://orcid.org/0000-0002-3873-315X'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elisa De Stanchina', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056561926', 'display_name': 'Nian Wu', 'orcid': 'https://orcid.org/0000-0001-5656-5703'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nian Wu', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049208970', 'display_name': 'Ouathek Ouerfelli', 'orcid': 'https://orcid.org/0000-0002-7038-0219'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ouathek Ouerfelli', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077906047', 'display_name': 'Peter J. Rix', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peter J. Rix', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014567706', 'display_name': 'Richard A. Heyman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard A. Heyman', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064589097', 'display_name': 'Michael E. Jung', 'orcid': 'https://orcid.org/0000-0003-1290-8588'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael E. Jung', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034963668', 'display_name': 'Charles L. Sawyers', 'orcid': 'https://orcid.org/0000-0003-4955-6475'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Charles L. Sawyers', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555', 'https://openalex.org/I1334819555']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5079488873', 'display_name': 'Jeffrey H. Hager', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Jeffrey H. Hager', 'raw_affiliation_strings': ['Aragon Pharmaceuticals, Inc., San Diego, California', "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Human Oncology & Pathogenesis Program, 2Howard Hughes Medical Institute, 3Organic Synthesis Core Facility, 4Molecular Pharmacology & Chemistry, 5Research Pharmacy Core Facility, 6Antitumor Assessment Core Facility, 7Analytical Pharmacology Core Facility, 8Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 10Aragon Pharmaceuticals, Inc., San Diego, California", 'institution_ids': ['https://openalex.org/I1334819555']}, {'raw_affiliation_string': 'Aragon Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5034963668', 'https://openalex.org/A5079488873'], 'corresponding_institution_ids': ['https://openalex.org/I1334819555', 'https://openalex.org/I1334819555'], 'apc_list': None, 'apc_paid': None, 'fwci': 48.808, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 633, 'citation_normalized_percentile': {'value': 0.99997, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '72', 'issue': '6', 'first_page': '1494', 'last_page': '1503'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10756', 'display_name': 'Estrogen and related hormone effects', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.9902, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bicalutamide', 'display_name': 'Bicalutamide', 'score': 0.7607734}], 'concepts': [{'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.8588975}, {'id': 'https://openalex.org/C2780962315', 'wikidata': 'https://www.wikidata.org/wiki/Q1988832', 'display_name': 'Bicalutamide', 'level': 5, 'score': 0.7607734}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6660483}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.61212605}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.56190515}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5550954}, {'id': 'https://openalex.org/C2779322244', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogen', 'level': 4, 'score': 0.5158469}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.47265187}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.46697497}, {'id': 'https://openalex.org/C2776235491', 'wikidata': 'https://www.wikidata.org/wiki/Q9625', 'display_name': 'Prostate', 'level': 3, 'score': 0.4459315}, {'id': 'https://openalex.org/C2779256933', 'wikidata': 'https://www.wikidata.org/wiki/Q58929', 'display_name': 'Castration', 'level': 3, 'score': 0.41539413}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.29435283}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.11753896}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.07542303}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018931', 'descriptor_name': 'Antineoplastic Agents, Hormonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018931', 'descriptor_name': 'Antineoplastic Agents, Hormonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018931', 'descriptor_name': 'Antineoplastic Agents, Hormonal', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D018931', 'descriptor_name': 'Antineoplastic Agents, Hormonal', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D049109', 'descriptor_name': 'Cell Proliferation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D049109', 'descriptor_name': 'Cell Proliferation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015972', 'descriptor_name': 'Gene Expression Regulation, Neoplastic', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D015972', 'descriptor_name': 'Gene Expression Regulation, Neoplastic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010669', 'descriptor_name': 'Phenylthiohydantoin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D013867', 'descriptor_name': 'Thiohydantoins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014105', 'descriptor_name': 'Tosyl Compounds', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D014105', 'descriptor_name': 'Tosyl Compounds', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D014105', 'descriptor_name': 'Tosyl Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 11, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc3306502', 'pdf_url': 'https://europepmc.org/articles/pmc3306502?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306502', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393733', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393733/1/files/39839309.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393727', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393727/1/files/39839303.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393724', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393724/1/files/39839300.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393721', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393721/1/files/39839297.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393718', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393718/1/files/39839294.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393715', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_1-7_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393715/1/files/39839291.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.22393730', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_ARN-509_A_Novel_Antiandrogen_for_Prostate_Cancer_Treatment/22393730/1/files/39839306.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22266222', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.can-11-3948', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.84, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 15, 'referenced_works': ['https://openalex.org/W1974810481', 'https://openalex.org/W1985580668', 'https://openalex.org/W2003955264', 'https://openalex.org/W2032651472', 'https://openalex.org/W2065173155', 'https://openalex.org/W2073100248', 'https://openalex.org/W2081365151', 'https://openalex.org/W2110534364', 'https://openalex.org/W2116458141', 'https://openalex.org/W2119504728', 'https://openalex.org/W2131848867', 'https://openalex.org/W2133489902', 'https://openalex.org/W2157592394', 'https://openalex.org/W2158734599', 'https://openalex.org/W2165782799'], 'related_works': ['https://openalex.org/W3148026613', 'https://openalex.org/W2413023094', 'https://openalex.org/W2165611177', 'https://openalex.org/W2069189563', 'https://openalex.org/W2065112594', 'https://openalex.org/W2010412515', 'https://openalex.org/W2002807096', 'https://openalex.org/W1983251925', 'https://openalex.org/W1976061403', 'https://openalex.org/W1816722347'], 'abstract_inverted_index': {'Abstract': [0], 'Continued': [1], 'reliance': [2], 'on': [3], 'the': [4, 20, 54, 153], 'androgen': [5], 'receptor': [6], '(AR)': [7], 'is': [8, 65], 'now': [9], 'understood': [10], 'as': [11, 199], 'a': [12, 60, 71, 124, 171, 176, 200], 'core': [13], 'mechanism': [14], 'in': [15, 37, 94, 106, 142, 184, 203], 'castration-resistant': [16, 207], 'prostate': [17, 88, 210], 'cancer': [18, 89], '(CRPC),': [19], 'most': [21], 'advanced': [22], 'form': [23], 'of': [24, 58, 76, 83, 109, 130, 150, 159, 195, 209], 'this': [25, 50, 143], 'disease.': [26], 'While': [27], 'established': [28], 'and': [29, 56, 73, 87, 93, 161, 206], 'novel': [30], 'AR': [31, 62, 69, 84, 117, 188], 'pathway–targeting': [32], 'agents': [33], 'display': [34], 'clinical': [35], 'efficacy': [36, 136], 'metastatic': [38], 'CRPC,': [39, 132], 'dose-limiting': [40], 'side': [41], 'effects': [42], 'remain': [43], 'problematic': [44], 'for': [45, 81, 116, 197], 'all': [46], 'current': [47, 187], 'agents.': [48], 'In': [49, 97, 123], 'study,': [51], 'we': [52], 'report': [53], 'discovery': [55], 'development': [57], 'ARN-509,': [59, 151], 'competitive': [61], 'inhibitor': [63], 'that': [64], 'fully': [66], 'antagonistic': [67], 'to': [68, 99, 179], 'overexpression,': [70], 'common': [72], 'important': [74], 'feature': [75], 'CRPC.': [77, 110], 'ARN-509': [78, 101, 112, 133, 167, 198], 'was': [79, 145], 'optimized': [80], 'inhibition': [82], 'transcriptional': [85], 'activity': [86, 105, 115], 'cell': [90], 'proliferation,': [91], 'pharmacokinetics,': [92], 'vivo': [95], 'efficacy.': [96], 'contrast': [98], 'bicalutamide,': [100], 'lacked': [102, 113], 'significant': [103], 'agonist': [104], 'preclinical': [107, 193], 'models': [108], 'Moreover,': [111], 'inducing': [114], 'nuclear': [118], 'localization': [119], 'or': [120], 'DNA': [121], 'binding.': [122], 'clinically': [125], 'valid': [126], 'murine': [127], 'xenograft': [128], 'model': [129, 144], 'human': [131], 'showed': [134], 'greater': [135, 177], 'than': [137, 186], 'MDV3100.': [138], 'Maximal': [139], 'therapeutic': [140, 173, 202], 'response': [141, 155], 'achieved': [146], 'at': [147], '30': [148], 'mg/kg/d': [149, 158], 'whereas': [152], 'same': [154], 'required': [156], '100': [157], 'MDV3100': [160], 'higher': [162, 172], 'steady-state': [163], 'plasma': [164], 'concentrations.': [165], 'Thus,': [166], 'exhibits': [168], 'characteristics': [169], 'predicting': [170], 'index': [174], 'with': [175], 'potential': [178], 'reach': [180], 'maximally': [181], 'efficacious': [182], 'doses': [183], 'man': [185], 'antagonists.': [189], 'Our': [190], 'findings': [191], 'offer': [192], 'proof': [194], 'principle': [196], 'promising': [201], 'both': [204], 'castration-sensitive': [205], 'forms': [208], 'cancer.': [211], 'Cancer': [212], 'Res;': [213], '72(6);': [214], '1494–503.': [215], '©2012': [216], 'AACR.': [217]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2084637523', 'counts_by_year': [{'year': 2024, 'cited_by_count': 34}, {'year': 2023, 'cited_by_count': 50}, {'year': 2022, 'cited_by_count': 56}, {'year': 2021, 'cited_by_count': 48}, {'year': 2020, 'cited_by_count': 65}, {'year': 2019, 'cited_by_count': 48}, {'year': 2018, 'cited_by_count': 52}, {'year': 2017, 'cited_by_count': 32}, {'year': 2016, 'cited_by_count': 44}, {'year': 2015, 'cited_by_count': 51}, {'year': 2014, 'cited_by_count': 63}, {'year': 2013, 'cited_by_count': 64}, {'year': 2012, 'cited_by_count': 22}], 'updated_date': '2024-12-20T09:20:08.909688', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
